The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Advances in targeting cyclic nucleotide phosphodiesterases
Open accessAbstract
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides, their signalling pathways and, consequently, myriad biological responses in health and disease. Currently, a small number of PDE inhibitors are used clinically for treating the pathophysiological dysregulation of cyclic nucleotide signalling in several disorders, including erectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease. However, pharmaceutical interest in PDEs has been reignited by the increasing understanding of the roles of individual PDEs in regulating the subcellular compartmentalization of specific cyclic nucleotide signalling pathways, by the structure-based design of novel specific inhibitors and by the development of more sophisticated strategies to target individual PDE variants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–222 of 222
Kass, D. A. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0101-0 · Cited by 34
Kelly, M. P., & Brandon, N. J. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17908-6 · Cited by 33
Cutshall, N. S., Onrust, R., Rohde, A. D., Gragerov, S., Hamilton, L., Harbol, K., Shen, H., McKee, S., Zuta, C., Gragerova, G., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.007 · Cited by 33
PDE3 inhibition in dilated cardiomyopathy
Movsesian, M. A., Wever‐Pinzon, O., & Vandeput, F. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.001 · Cited by 31
Structural Insight into the Substrate Specificity of Phosphodiesterases
Ke, H., Wang, H., & Ye, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_4 · Cited by 29
Self-citationHuai, Q., Sun, Y., Wang, H., Macdonald, D., Aspiotis, R., Robinson, H., Huang, Z., & Ke, H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051273d · Cited by 28
Self-citationKeravis, T. M., Monneaux, F., Yougbaré, I., Gazi, L., Bourguignon, J., Muller, S., & Lugnier, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028899 · Cited by 28
Guirguis, E., Hockman, S. C., Chung, Y. W., Ahmad, F., Gavrilova, O., Raghavachari, N., Yang, Y., Niu, G., Chen, X. S., Yu, Z., et al. (2013) · Endocrinology · doi:10.1210/en.2012-2185 · Cited by 28
Self-citationRapid Identification of a Novel Small Molecule Phosphodiesterase 10A (PDE10A) Tracer
Hu, E., Ma, J., Biorn, C., Lester-Zeiner, D., Cho, R., Rumfelt, S., Kunz, R. K., Nixey, T. E., Michelsen, K., Miller, S., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3002372 · Cited by 28
Geng, D.-F., Liu, M., Jin, D., Wu, W., Deng, J., & Wang, J. (2012) · Cardiology · doi:10.1159/000338812 · Cited by 27
Piccart, E., Gantois, I., Laeremans, A., Hoogt, R. D., Meert, T. F., Vanhoof, G., Arckens, L., & D’Hooge, R. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.11.018 · Cited by 25
Discovery of 4-hydroxy-1,6-naphthyridine-3-carbonitrile derivatives as novel PDE10A inhibitors
Bauer, U., Giordanetto, F., Bauer, M., O’Mahony, G., Johansson, K. E., Knecht, W., Hartleib‐Geschwindner, J., Carlsson, E. T., & Enroth, C. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.046 · Cited by 25
Huo, Z., Ye, J., Chen, J., Lin, X., Zhou, Z.-N., Xu, X., Li, C.-M., Qi, M., Liang, D., Liu, Y., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.09.005 · Cited by 25
Bäumer, W., Gorr, G., Hoppmann, J., Ehinger, A. M., Rundfeldt, C., & Kietzmann, M. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021585 · Cited by 24
Discovery of oxazole-based PDE4 inhibitors with picomolar potency
Kuang, R., Shue, H., Xiao, L., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.115 · Cited by 23
Phosphodiesterases and regulation of female reproductive function
Conti, M. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.004 · Cited by 22
Mak, G., & Hanania, N. A. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.019 · Cited by 21
Subcellular signaling in the endothelium: cyclic nucleotides take their place
Maurice, D. H. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.009 · Cited by 20
Self-citationYougbaré, I., Boire, G., Roy, M., Lugnier, C., & Rouseau, É. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0233 · Cited by 18
Tetomilast: new promise for phosphodiesterase-4 inhibitors?
Bickston, S. J., Snider, K. R., & Kappus, M. R. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.732065 · Cited by 16
Labuda, M., Laberge, S., Brière, J., Bérubé, D., Beaulieu, P., Pastinen, T., & Krajinović, M. (2011) · Mediators of Inflammation · doi:10.1155/2011/301695 · Cited by 12
The Next Century of Endocrinology
Gore, A. C. (2012) · Endocrinology · doi:10.1210/en.2012-2174 · Cited by 3
Cited by
Regulation of tumour necrosis factor signalling: live or let die
Brenner, D., Blaser, H., & Mak, T. W. (2015) · Nature Reviews Immunology · doi:10.1038/nri3834 · Cited by 998
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases
Li, H., Zuo, J., & Tang, W. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01048 · Cited by 580
Hydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
Li, L., Yin, Q., Kuss, P., Maliga, Z., Millán, J. L., Wu, H., & Mitchison, T. J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1661 · Cited by 533
Transcriptional Architecture of Synaptic Communication Delineates GABAergic Neuron Identity
Paul, A., Crow, M., Raudales, R., He, M., Gillis, J., & Huang, Z. J. (2017) · Cell · doi:10.1016/j.cell.2017.08.032 · Cited by 421
Molecular Physiology of Membrane Guanylyl Cyclase Receptors
Kuhn, M. (2016) · Physiological Reviews · doi:10.1152/physrev.00022.2015 · Cited by 356
Metadata
- Authors
- Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J., & Manganiello, V. C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-04
- Volume
- 13
- Issue
- 4
- Pages
- 290-314
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1972029787
- Cited by
- 776
- References
- 222
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.